Short Interest in Celularity Inc. (NASDAQ:CELUW) Rises By 89.3%

Celularity Inc. (NASDAQ:CELUW) was the recipient of a large increase in short interest in the month of July. As of July 15th, there was short interest totaling 106,447 shares, an increase of 89.3% from the June 30th total of 56,239 shares. Based on an average daily volume of 165,384 shares, the short-interest ratio is presently 0.6 days.

Celularity Price Performance

CELUW stock opened at $0.00 on Thursday. Celularity has a 1 year low of $0.00 and a 1 year high of $0.06.

Celularity Company Profile

Celularity, Inc is a clinical-stage biotechnology company headquartered in Florham Park, New Jersey, that specializes in the development and commercialization of allogeneic “off-the-shelf” cell therapies derived from postpartum placental cells. Leveraging a proprietary platform of placental- and umbilical-derived cells, the company seeks to deliver immune-modulatory, regenerative and anti-inflammatory treatments across oncology, immunology and other therapeutic areas. By harnessing the natural properties of placental cells, Celularity aims to overcome the limitations of autologous therapies and scale production to serve a broad patient population.

The company’s pipeline includes CYNK-001, an investigational natural killer (NK) cell therapy being evaluated for hematological malignancies and solid tumors, as well as other cell-based programs targeting viral infections and tissue repair.